IFNG and glioblastoma: Second, we searched for the appearance of W>F substitutants in the immunopeptidome of the glioblastoma cell line RA, in which we previously detected their enrichment in the proteome following IFNγ treatment (Fig. 2f, Extended Data Fig. 2m, Supplementary Table 9).